Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

209 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multi-hit TET2 mutations as a differential molecular signature of oligomonocytic and overt chronic myelomonocytic leukemia.
Garcia-Gisbert N, Arenillas L, Roman-Bravo D, Rodriguez-Sevilla JJ, Fernández-Rodríguez C, Garcia-Avila S, Velez P, Gibert J, Fernández-Ibarrondo L, Salar A, Florensa L, Bellosillo B, Ferrer A, Calvo X. Garcia-Gisbert N, et al. Among authors: florensa l. Leukemia. 2022 Dec;36(12):2922-2926. doi: 10.1038/s41375-022-01733-8. Epub 2022 Oct 22. Leukemia. 2022. PMID: 36273104 No abstract available.
Identification of Two Novel EPOR Gene Variants in Primary Familial Polycythemia: Case Report and Literature Review.
Lo Riso L, Vargas-Parra G, Navarro G, Arenillas L, Fernández-Ibarrondo L, Robredo B, Ballester C, López B, Perez-Montaña A, Sampol A, Florensa L, Besses C, Duran MA, Bellosillo B. Lo Riso L, et al. Among authors: florensa l. Genes (Basel). 2022 Sep 20;13(10):1686. doi: 10.3390/genes13101686. Genes (Basel). 2022. PMID: 36292571 Free PMC article. Review.
Leukemic Involvement Is a Common Feature in Waldenström Macroglobulinemia at Diagnosis.
Montesdeoca S, García-Gisbert N, Calvo X, Arenillas L, Román D, Fernández-Rodríguez C, Navarro R, Costan B, Vela MDC, Camacho L, Abella E, Colomo L, Salido M, Puiggros A, Florensa L, Espinet B, Bellosillo B, Ferrer Del Álamo A. Montesdeoca S, et al. Among authors: florensa l. Cancers (Basel). 2023 Aug 17;15(16):4152. doi: 10.3390/cancers15164152. Cancers (Basel). 2023. PMID: 37627180 Free PMC article.
Outcomes and molecular profile of oligomonocytic CMML support its consideration as the first stage in the CMML continuum.
Calvo X, Roman-Bravo D, Garcia-Gisbert N, Rodriguez-Sevilla JJ, Garcia-Avila S, Florensa L, Gibert J, Fernández-Rodríguez C, Salido M, Puiggros A, Espinet B, Colomo L, Bellosillo B, Ferrer A, Arenillas L. Calvo X, et al. Among authors: florensa l. Blood Adv. 2022 Jul 12;6(13):3921-3931. doi: 10.1182/bloodadvances.2022007359. Blood Adv. 2022. PMID: 35709473 Free PMC article.
Oligomonocytic and overt chronic myelomonocytic leukemia show similar clinical, genomic, and immunophenotypic features.
Calvo X, Garcia-Gisbert N, Parraga I, Gibert J, Florensa L, Andrade-Campos M, Merchan B, Garcia-Avila S, Montesdeoca S, Fernández-Rodríguez C, Salido M, Puiggros A, Espinet B, Colomo L, Roman-Bravo D, Bellosillo B, Ferrer A, Arenillas L. Calvo X, et al. Among authors: florensa l. Blood Adv. 2020 Oct 27;4(20):5285-5296. doi: 10.1182/bloodadvances.2020002206. Blood Adv. 2020. PMID: 33108455 Free PMC article.
Multidimensional assessment of patient condition and mutational analysis in peripheral blood, as tools to improve outcome prediction in myelodysplastic syndromes: A prospective study of the Spanish MDS group.
Ramos F, Robledo C, Pereira A, Pedro C, Benito R, de Paz R, Del Rey M, Insunza A, Tormo M, Díez-Campelo M, Xicoy B, Salido E, Sánchez-Del-Real J, Arenillas L, Florensa L, Luño E, Del Cañizo C, Sanz GF, María Hernández-Rivas J; Spanish Group for Myelodysplastic Syndromes (GESMD). Ramos F, et al. Among authors: florensa l. Am J Hematol. 2017 Sep;92(9):E534-E541. doi: 10.1002/ajh.24813. Epub 2017 Jul 19. Am J Hematol. 2017. PMID: 28612357 Free article. Clinical Trial.
Enumerating bone marrow blasts from nonerythroid cellularity improves outcome prediction in myelodysplastic syndromes and permits a better definition of the intermediate risk category of the Revised International Prognostic Scoring System (IPSS-R).
Calvo X, Arenillas L, Luño E, Senent L, Arnan M, Ramos F, Pedro C, Tormo M, Montoro J, Díez-Campelo M, Blanco ML, Arrizabalaga B, Xicoy B, Bonanad S, Jerez A, Nomdedeu M, Ferrer A, Sanz GF, Florensa L. Calvo X, et al. Among authors: florensa l. Am J Hematol. 2017 Jul;92(7):614-621. doi: 10.1002/ajh.24732. Epub 2017 May 9. Am J Hematol. 2017. PMID: 28370234 Free article.
209 results